2012
DOI: 10.4314/tjpr.v11i4.20
|View full text |Cite
|
Sign up to set email alerts
|

Why Don’t Medical Practitioners Treat Malaria Rationally? A Qualitative Study from Pakistan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
3
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 11 publications
1
3
0
Order By: Relevance
“…Given the relative affordability and accessibility of non-artemisinin therapies, health workers at private health facilities are likely to choose incorrect and ineffective antimalarial drugs for the treatment of malaria. This finding is in line with the results of a study done by Malik et al [15] which assessed the quality of anti-malarial drugs provided by public and private healthcare providers and found that monotherapies such as chloroquine, SP, quinine, artesunate, and dihydroartemisinin were still widely used for treatment of malaria.…”
Section: Discussionsupporting
confidence: 90%
“…Given the relative affordability and accessibility of non-artemisinin therapies, health workers at private health facilities are likely to choose incorrect and ineffective antimalarial drugs for the treatment of malaria. This finding is in line with the results of a study done by Malik et al [15] which assessed the quality of anti-malarial drugs provided by public and private healthcare providers and found that monotherapies such as chloroquine, SP, quinine, artesunate, and dihydroartemisinin were still widely used for treatment of malaria.…”
Section: Discussionsupporting
confidence: 90%
“…Hence, unless health workers and community members are informed through appropriate channels about the most effective tools for preventing and treating malaria, their welfare will suffer [ 13 ]. Other studies found that health care workers provided inappropriate treatment due to lack of awareness of appropriate malaria treatment guidelines [ 25 , 27 31 ].…”
Section: Discussionmentioning
confidence: 99%
“…Chloroquine is no longer indicated for treatment of P. falciparum but is recommended in combination with primaquine for treatment of P. vivax . Although the nature of anti-malarial use in Pakistan is not well-characterized, the availability of SP and other drugs as monotherapy has been documented [48] and, along with misdiagnosis of mixed infections [49] and presumptive treatment [50], likely results in P. vivax infections being frequently treated with AS + SP or SP alone. This study sought to characterize the current distribution of chloroquine resistance-associated polymorphisms in pvmdr1 and SP resistance-associated point mutations in pvdhfr and pvdhps in Pakistan.…”
Section: Discussionmentioning
confidence: 99%